IRulya Therapeutics QNCX
NASDAQ QNCX
$34.45 +2.42 (+7.56%)
At close: Oct 19, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Common Equity (2018 - 2026)

Updated

Quince Therapeutics' Common Equity came in at -$35.32 million for Q2 2026, compared with $11.74 million a year earlier.

Analysis

Quince Therapeutics, Inc. (QNCX) Common Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Quince Therapeutics' Common Equity was -$35.71 million.

  • Going back by year, Common Equity was $30.15 million in FY2024 (-64.6%), $85.08 million in FY2023 (-15.4%), $100.59 million in FY2022 (-15.2%) and $118.59 million in FY2021 (-31.2%).
  • The five-year range for quarterly Common Equity is -$35.71 million (Q4 2025) to $132.65 million (Q3 2021).
  • Across the past five years, year-over-year decline in Common Equity ran from 15.2% in Q4 2022 to 97.6% in Q3 2025.
  • Business Quant data shows QNCX's Common Equity at $15.67 million (Q1 2026), -$35.71 million (Q4 2025) and $1.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.32 Mn
Mar 31, 2026 15.67 Mn
Dec 31, 2025 -35.71 Mn
Sep 30, 2025 1.06 Mn
Jun 30, 2025 11.74 Mn
Mar 31, 2025 18.58 Mn
Dec 31, 2024 30.15 Mn
Sep 30, 2024 44.93 Mn
Jun 30, 2024 46.97 Mn
Mar 31, 2024 74.18 Mn
Dec 31, 2023 85.08 Mn
Sep 30, 2023 83.13 Mn
Jun 30, 2023 86.88 Mn
Mar 31, 2023 90.20 Mn
Dec 31, 2022 100.59 Mn
Sep 30, 2022 104.53 Mn
Jun 30, 2022 111.53 Mn
Mar 31, 2022 106.38 Mn
Dec 31, 2021 118.59 Mn
Sep 30, 2021 132.65 Mn
API Access

Quince Therapeutics, Inc. Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=QNCX&period=max&api_key=YOUR_API_KEY